| ²é¿´: 3587 | »Ø¸´: 11 | |||
[½»Á÷]
Ͷ³öһƪÎÄÕ£¬Ò»¸öÉó¸åÈËͬÒ⣬һ¸ö²»Í¬Òâ¡£ÎÒÏëÉêËߣ¬Çó½Ì
|
| Ͷ³öһƪÎÄÕ£¬Ò»¸öÉó¸åÈËͬÒ⣬һ¸ö²»Í¬Òâ¡£±à¼×îºó¸ø¾Ü¾øÁË¡£²»Í¬ÒâµÄÒâ¼ûÓÐËÄÌõ£¬ÎÒ¾õµÃÓÐÁ½ÌõÒÔÉÏÌáµÄ²»ÊǺܺÏÀí£¬ÐÄÀï¾õµÃºÜίÇü£¬ËùÒÔÏëÉêËßһϡ£µ«ÊDz»ÖªµÀÓ¦¸ÃÔõôд£¬»òÕßÓÐûÓÐÏà¹ØµÄ´ë´Ç¹æ¾Ø¡£ÒòΪµÚÒ»´ÎÓö¼ûÕâÖÖÇé¿ö£¬ËùÒÔÏëÇë½Ì´ó¼Ò£¬ÎҸò»¸ÃÉêËߣ¬ÒªÊÇÓ¦¸Ã¸ÃÔõôд¡£ÏÖÔÚÐÄÀïºÜÂÒ¡£ËùÒÔÇó½ÌÓйýÀàËÆ¾ÀúµÄÈËÌá³ö±¦¹óÒâ¼û²»Ê¤¸Ð¼¤¡£ |
» ²ÂÄãϲ»¶
299Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
083200ѧ˶321·ÖÒ»Ö¾Ô¸ôßÄÏ´óѧÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
³õʼ318·ÖÇóµ÷¼Á£¨Óй¤×÷¾Ñ飩
ÒѾÓÐ3È˻ظ´
¶þ±¾¿ç¿¼Ö£´ó²ÄÁÏ306Ó¢Ò»Êý¶þ
ÒѾÓÐ3È˻ظ´
»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÖйúʯÓÍ´óѧ£¨»ª¶«£© ±¾¿ÆÆë³¹¤Òµ´óѧ
ÒѾÓÐ3È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑоÀú
ÒѾÓÐ8È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
IEEE Ͷ¸åºóÖ»·µ»ØÒ»¸öר¼ÒµÄÉó¸åÒâ¼û£¬ÆäËü6¸öÉó¸åÈ˶¼¾ÜÉó£¬ÎÄÕ»¹ÓÐÏ£ÍûÂð£¿
ÒѾÓÐ16È˻ظ´
materials and designÉó¸åÈËͬÒ⣬±à¼¾Ü¸å¸ÅÂʶà´ó£¿
ÒѾÓÐ8È˻ظ´
Öйúµç»ú¹¤³Ìѧ±¨ÊDz»ÊÇÖ»ÒªÒ»¸öÉó¸åÈ˲»Í¬Òâ¾Í¾Ü¸å£¬Òª²»ÒªÏò±à¼ËµÃ÷Ò»ÏÂÇé¿ö
ÒѾÓÐ29È˻ظ´
J. Power Sources Éó¸åÒâ¼ûÒ»¸öͬÒâÒ»¸ö¾Ü¾ø£¬Âé·³´ó¼Ò¿´¿´£¬ÓбØÒªÉêËßÂð
ÒѾÓÐ8È˻ظ´
Ò»¸öÉó¸åÈ˲»Í¬Ò⣬ÔÙËÍÉ󣬻¹ÓÐÏ£ÍûÂð£¿
ÒѾÓÐ5È˻ظ´
ͶÁËһƪӢÎÄÎÄÕ£¬Éó¸åÈ˿϶¨ÁËÏë·¨£¬µ«Êǽ¨Òé¾Ý¸å¡£¿ÉÖ÷±à¸ø³ö´óÐÞ¡£
ÒѾÓÐ22È˻ظ´
Bioorganic & Medicinal Chemistry LettersһƪÎÄÕÂÒª¼¸¸öÉó¸åÈË
ÒѾÓÐ5È˻ظ´
Á½¸öÉó¸åÈË£¬Ò»¸ö°ÑÎÄÕÂÂîµÃһǮ²»Öµ£¬Ò»¸ö˵СÐÞһϼ´½ÓÊÜ£¬±à¼µÄ½áÂÛÊÇÐÞ¸Ä
ÒѾÓÐ42È˻ظ´
ÎÄÕÂÐ޸ĺó£¬Éó¸åÈË×¥×ÅÒ»¸öСÎÊÌâ²»·Å£¬Çë½Ì¸÷λ
ÒѾÓÐ8È˻ظ´
Éó¸åÈËÓÐ6¸ö£¬Ð޸ĸåҪȫͬÒâ²ÅÄÜ·¢±íÂï
ÒѾÓÐ7È˻ظ´
ǧ¹ÅÆæÔ©¡£¡£±¯¾ç¡£¡£´óÐÞºóÉó¸åÈËͬÒâ·¢£¬Ö÷±à²»Í¬Òâ
ÒѾÓÐ38È˻ظ´
Ò»¸öÉó¸åÈ˶ÔÎÄÕÂûÓÐÒâ¼û£¬Ôõô¸Ðл
ÒѾÓÐ17È˻ظ´
jacsÓÐÒ»¸öÉó¸åÈ˲»Í¬Òâ·¢±í£¬»¹ÓÐûÓÐÏ£Íû£¿
ÒѾÓÐ23È˻ظ´
ͶSCI´óÐÞ£¬Éó¸åÈË2¸öͬÒâÒ»¸ö¾Ü¸å
ÒѾÓÐ18È˻ظ´
20Ìì¹ýÈ¥ÁË£¬colloids and surfaces B Ö»ÓÐÒ»¸öÉó¸åÈËͬÒâÉó¸å£¬Õý³£Âð£¿
ÒѾÓÐ8È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
Çൺ¸ßУ2026ÕÐÉú˶ʿÑо¿Éú
+5/780
ũҵÐÅÏ¢¹¤³Ì¼¼Êõ£¨×¨Ë¶£©ÕÐÊÕµ÷¼Á ÉòÑôũҵ´óѧ
+1/184
µçÁ¦È«¹úÖØµãʵÑéÊÒ˫һÁ÷AÀ೤½Ñ§ÕßÍŶÓÕÐ2026ÄêÈ«ÈÕÖÆ²©Ê¿1Ãû£¨4ÔÂ3ÈÕ½ØÖ¹£©
+2/100
ÖйúµçÆø×°±¸¼¯ÍÅÑо¿ÔºÕÐÊÕAI+²ÄÁϵÈÏà¹Ø¸ÚλʵϰÉú
+1/88
²ÄÁÏ¡¢»¯Ñ§Àà˶ʿÑо¿Éúµ÷¼Á»ú»á£¬Ñ§Ë¶×¨Ë¶¾ù¿É£¬ÓÐÒâÇëÁªÏµ£¬·Ç³ÏÎðÈÅ£¡
+1/88
ÎÄÏ×·ÖÏí£¬»¶ÓÒýÓÃ
+1/85
¼ÃÄÏ´óѧÁÖÐã¾ê½ÌÊÚÕÐÊÕ²ÄÁÏÀ಩ʿÉú
+1/84
ÖØÇìÒ½¿Æ´óѧÉñ¾¿ÆÑ§ÖÐÐÄ/²¡ÉúÓëÉúÀíϵ³ÏÑûº£ÄÚÍâÓÅÐ㲩ʿ¼ÓÃ˲©Ê¿ºó¶ÓÎ飨³¤ÆÚ£©
+1/81
ÏæÌ¶´óѧ»¯¹¤Ñ§Ôº¹ú¼Ò¼¶È˲ÅÍŶÓ2026Ä격ʿÑо¿ÉúÕÐÉú
+1/60
ÕÐÊÕ2026Äê²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á£¬È«¹úÖØµãʵÑéÊÒ£¬¹ý¹ú¼ÒÏß¼´¿Éµ÷¼Á£¬Ãû¶î³ä×ã
+2/50
¸Õ¸Õ¹¤×÷²»¾ÃµÄ¹Â¶À¸Ð
+1/34
ÉϺ£½»Í¨´óѧÉòµÀÖǸ±½ÌÊÚÕÐÊÕ2026ÄêÁªÅ಩ʿ/˶ʿÑо¿Éú£¨Î¢ÄÉÆ÷¼þÓëÖÆÔì·½Ïò£©
+1/33
ÖÐɽ´óѧԺʿÍŶÓ΢ÄÉÆ÷¼þ¡¢ÄÔ»ú½Ó¿Ú·½Ïò²©Ê¿ÕÐÉú¡¢²©ºóÕÐÆ¸
+1/18
¡¾ÉîÛÚÀí¹¤´óѧ¡¿ÔºÊ¿¹¤×÷Õ¾ÕÐÆ¸²©Ê¿ºó-µç´ß»¯ºÍÓлúµç»¯Ñ§
+1/15
26Ä격ʿ×Ô¼ö
+1/14
ºÓÄÏ´óѧ¹¨ºÍ¹ó½ÌÊÚ2026Ä격ʿÑо¿ÉúÕÐÉú
+1/5
¹ú¼Ò¼¶È˲ÅÍÅ¶Ó³ÏÆ¸ÉúÎïÐÅÏ¢Ïà¹Ø×¨ÒµµÄ¿ÆÑÐÖúÀí
+1/4
À¥Ã÷Àí¹¤´óѧ³Â½ÕÕ½ÌÊÚÍŶӲ©Ê¿ÕÐÉú
+1/4
ÕÐÊÕ»¯¹¤Óë²ÄÁÏѧ¿ÆµãÑо¿Éú
+1/3
ÖпÆÔºÉϺ£Î¢ÏµÍ³Ëù²ÄÁÏÉú³¤ÀíÂÛÓë·ÂÕæ¿ÎÌâ×é-²©Ê¿ºóÕÐÆ¸£¨²ÄÁϼÆËãÓëAI4S£©
+1/2
hlzhlqq(½ð±Ò+1): 2011-02-20 16:18:48
|
Ê×ÏȰ´ÕÕÁ½¸öÉó¸åÈ˵ÄÒâ¼û½«ÎÄÕÂÐ޸ĺã¬Ð´ºÃresponse, revised/marked-manuscript, letter£» ÔÚresponseÖУ¬×¢Òâ´ë´Ç£¬ËµÃ÷ÄǸö·´¶ÔÈ˵ÄÐÞ¸ÄÒâ¼ûΪʲô²»¶Ô£¬°´1¡¢2¡¢3Ö®ÀàµÄÂÞÁУ¬ÕâÑù£¬Éó¸åÈËÔĶÁµÄʱºò¾ÍһĿÁËÈ»£¬ºÜÈÝÒ׿´¶®£»ÔÚ¸øEditorµÄletterÖУ¬Ö¸³ö·´¶ÔÉó¸åÈ˵ĴíÎó£¬Í¬Ê±Î¯ÍñµØÒªÇó±à¼ÖØÐ¿¼ÂÇһϡ£¡£¡£ [ Last edited by hqzhou0817 on 2011-2-20 at 14:29 ] |
2Â¥2011-02-20 14:28:41
tangbohejin
ľ³æÖ®Íõ (ÎÄѧ̩¶·)
- Ó¦Öú: 78 (³õÖÐÉú)
- ½ð±Ò: 124581
- Ìû×Ó: 120069
- ÔÚÏß: 3094.2Сʱ
- ³æºÅ: 280555
3Â¥2011-02-20 14:29:37
leipei.123
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 12620.5
- Ìû×Ó: 16536
- ÔÚÏß: 686.8Сʱ
- ³æºÅ: 951478
4Â¥2011-02-20 14:53:36
davidfrela
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 12506.6
- Ìû×Ó: 14714
- ÔÚÏß: 341.9Сʱ
- ³æºÅ: 314160
5Â¥2011-02-20 14:55:18
liuxing1-1
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- SEPI: 1
- Ó¦Öú: 9 (Ó×¶ùÔ°)
- ¹ó±ö: 0.001
- ½ð±Ò: 12867
- Ìû×Ó: 7796
- ÔÚÏß: 1475.7Сʱ
- ³æºÅ: 825034
6Â¥2011-02-20 15:01:02
liudb
ľ³æ (ÖøÃûдÊÖ)
- SEPI: 1
- Ó¦Öú: 85 (³õÖÐÉú)
- ¹ó±ö: 0.001
- ½ð±Ò: 608.2
- Ìû×Ó: 1713
- ÔÚÏß: 809.1Сʱ
- ³æºÅ: 461357
hlzhlqq(½ð±Ò+5): ¶àлÄúµÄ°ïÖú 2011-02-20 16:15:46
|
Dear XX, Thank you for your and the two Reviewers¡¯ efforts in the review of our manuscript entitled ¡°XXXX¡± for consideration as XX in XXX. You gave us very important comments and suggestions, which have helped us to improve our manuscript. Reviewer 1 gave us lots of helpful suggestions and thought that our work eventually might be publishable after some revisions. Reviewer 2 thought our manuscript XXXX. We have carefully carried out additional experiments and improved the manuscript as Reviewer 1 and 2 suggested, such as XXXX, which consistently proves our original proposed XXXX. In addition, ¸ü¶àÖØÒªÀíÓÉ Therefore, we sincerely hope you could reconsider our manuscript for publication in XXXX. The detailed responses to the comments from the Reviewers are listed as follows: ÖðÌõÈÏÕæµÄ»Ø¸´Á½¸öÉó¸åÈËÒâ¼û£¬ÓÈÆä¶ÔµÚ¶þ¸öÉó¸åÈËÒâ¼ûÒªÓÐÀíÓоݵĻظ´¡£ [ Last edited by liudb on 2011-2-20 at 15:23 ] |
7Â¥2011-02-20 15:20:42
visitor958
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 2283 (½²Ê¦)
- ¹ó±ö: 0.05
- ½ð±Ò: 17310
- Ìû×Ó: 15735
- ÔÚÏß: 2926.6Сʱ
- ³æºÅ: 489254
8Â¥2011-02-20 15:23:15
lwiaanngg
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 46 (СѧÉú)
- ¹ó±ö: 0.773
- ½ð±Ò: 7403.2
- Ìû×Ó: 1211
- ÔÚÏß: 110.3Сʱ
- ³æºÅ: 43541
hlzhlqq(½ð±Ò+2): 2011-02-21 14:20:25
|
ÏÈÀä¾²Ò»ÏÂÁË£¬×÷¾ö¶¨µÄʱºò£¬¹Ø¼üÊDz»Òª±»Éó¸åÒâ¼ûËù×óÓÒ¡£ ¼ÈÈ»EditorÓÉÓÚµÚ¶þ¸öreviewerµÄÒâ¼û¾ÜÁË£¬Ò²¾ÍÒâζ×ÅEditor±È½ÏÔÞͬËûµÄÒâ¼û¡£Òª²»Editor»áÕÒµÚÈý¸ö¿´¿´µÄ¡£ËùÒÔ£¬Àä¾²ÏÂÀ´ºÃºÃ¿´¿´µÚ¶þ¸öµÄÒâ¼û£¬¾¡Á¿ÍêÉÆÒ»ÏÂÎÄÕÂÁË¡£ ÖÁÓÚÊÇ·ñÉêËߣ¬ÎÒ¾õµÃ»¹ÊǶ࿼ÂÇÒ»ÏÂÁË£¬±Ï¾¹EditorĿǰ²»Õ¾ÔÚÄãµÄÕâ±ß¡£ Ï£Íû¶ÔÄãÓаïÖúÁË£¬×£ÔçÈÕ½ÓÊÜ |
9Â¥2011-02-21 13:07:04
10Â¥2011-02-21 14:02:15
11Â¥2011-02-21 14:04:50
yexuqing
ľ³æÖ®Íõ (ÎÄѧ̩¶·)
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 200105
- Ìû×Ó: 168234
- ÔÚÏß: 4904.3Сʱ
- ³æºÅ: 88288
12Â¥2011-02-21 14:09:24













»Ø¸´´ËÂ¥